Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Total Equity history
Currency unavailable · from the balance sheet
No Total Equity data reported for this period type.
Total Equity vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $631.42M USD | -18.9% | +16.7% | 89.6% | |
| Mar 2026 | $234.1M USD | — | — | 80.1% | |
| Mar 2026 | $167.62M USD | +95.5% | +101.8% | 96.7% | |
| Mar 2026 | $106.19M USD | -11.1% | -20.3% | 78.6% | |
| Jun 2026 | -$173.49M USD | +52.9% | — | 9.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +20.9% | +16.7% | 80.1% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.